rs142433332
Variant summary
Our verdict is Likely pathogenic. The variant received 6 ACMG points: 6P and 0B. PVS1_ModeratePM2PP5_Moderate
The NM_018122.5(DARS2):c.492+2T>A variant causes a splice donor, intron change. The variant allele was found at a frequency of 0.00000207 in 1,451,198 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★).
Frequency
Consequence
NM_018122.5 splice_donor, intron
Scores
Clinical Significance
Conservation
Publications
- leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndromeInheritance: AR, AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P, Orphanet
- mitochondrial diseaseInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 6 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| DARS2 | NM_018122.5 | c.492+2T>A | splice_donor_variant, intron_variant | Intron 5 of 16 | ENST00000649689.2 | NP_060592.2 | ||
| DARS2 | NM_001365212.1 | c.492+2T>A | splice_donor_variant, intron_variant | Intron 5 of 15 | NP_001352141.1 | |||
| DARS2 | NM_001365213.2 | c.492+2T>A | splice_donor_variant, intron_variant | Intron 5 of 13 | NP_001352142.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD2 exomes AF: 0.00000797 AC: 2AN: 251028 AF XY: 0.0000147 show subpopulations
GnomAD4 exome AF: 0.00000207 AC: 3AN: 1451198Hom.: 0 Cov.: 28 AF XY: 0.00000415 AC XY: 3AN XY: 722742 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome Pathogenic:1
The c.492+2T>A variant in DARS2 has not been previously reported in the literature in individuals with leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome, but has been identified in 0.003% (2/60000) of Admixed American chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP ID: rs142433332). Although this variant has been seen in the general population in a heterozygous state, its frequency is low enough to be consistent with a recessive carrier frequency. This variant is located in the 3' splice region. Computational tools predict a splicing impact, though this information is not predictive enough to determine/rule out pathogenicity. This variant is adjacent to an in-frame exon and is more likely to escape nonsense mediated decay (NMD) and result in a truncated protein. Loss of function of the DARS2 gene is an established disease mechanism in leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome. One additional pathogenic variant, predicted to induce the same splicing effect as this variant, has been reported in ClinVar as being associated with leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome, supporting that the c.492+1G>A variant may be pathogenic (Variation ID: 1062). In summary, although additional studies are required to fully establish its clinical significance, this variant is likely pathogenic for autosomal recessive leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome. ACMG/AMP Criteria applied: PS1, PVS1_moderate, PM2_supporting (Richards 2015). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at